FBN2 and Weill-Marchesani syndrome: In summary, we have shown that fibrillin-2 TB5 binds HS weakly compared to fibrillin-1, mapped two heparin binding sites on fibrillin-1 TB5, and shown that disease-causing WMS, AD and GD mutations all map to, and disrupt heparin binding.